Lobe Sciences Invites You to Join Us at the Q2 Virtual Investor Summit

May 12, 2021

Vancouver, British Columbia--(Newsfile Corp. - May 12, 2021) - Lobe Sciences (CSE: LOBE) today announced that Philip Young, CEO and Director, will be attending the Q2 Virtual Investor Summit.

Event Q2 Investor Summit

Date May 17-18th, 2021

Presentation May 18th at 10:15 AM ET

Location https://zoom.us/webinar/register/WN_9O2Bo2GAS-Ks6W5cFJKFWQ

About Lobe Sciences

Lobe is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

For further information:

Lobe Sciences
Philip Young CEO & Director
(949) 505-5623

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com.


Sasha Murray at sasha@investorsummitgroup.com

Always do your own research and make your own investment decisions. This is not a solicitation to purchase or sell securities. Psychedelic Finance is not a registered investment advisor and does not purport to provide investment advice, whether implied or otherwise. Psychedelic Finance does not independently verify the accuracy or the truth of the statements or representations made by issuers. This message is meant for information and educational purposes only and Psychedelic Finance does not intend for this information to be used to inform an investment decision.